Back
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek
J. Cancer Ther. Vol.8 No.2, February 16, 2017  DOI: 10.4236/jct.2017.82015
       (PDF  452K)     HTML      XML
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski
J. Cancer Ther. Vol.7 No.12, November 04, 2016  DOI: 10.4236/jct.2016.712083
       (PDF  1314K)     HTML      XML
A Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Brainstem Gliomas. The Report on Non-Diffuse Intrinsic Pontine Glioma (Protocol BT-11)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek
J. Cancer Ther. Vol.6 No.4, April 13, 2015  DOI: 10.4236/jct.2015.64036
       (PDF  473K)     HTML      XML
Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Advanced Malignant Mesothelioma: A Strategy for Improved Survival
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Sheldon Brookman
J. Cancer Ther. Vol.5 No.12, October 29, 2014  DOI: 10.4236/jct.2014.512116
       (PDF  3640K)     HTML     
Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Recurrent Advanced Pancreatic Cancer—A Potential Strategy for Improved Survival
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Sheldon Brookman
J. Cancer Ther. Vol.5 No.12, October 28, 2014  DOI: 10.4236/jct.2014.512113
       (PDF  2980K)     HTML     
 
 
Top